How Startup Fundraising Works | Startup School

Fundraising Realities vs. Myths

• Myth 1: Fundraising is glamorous.

  • Reality: Actual fundraising resembles a grind of one-on-one meetings (Zoom or coffee chats) rather than high-pressure pitch competitions like Shark Tank.
  • Evidence: Fresh Paint (YC company) met 160 investors over 4 months and 18 days to raise $1.6 million; 39 said yes, with checks ranging from $5,000 to $200,000.
  • Fact: Investors often use pitch competitions as networking events and may not invest at all (e.g., Mark Cuban noted he was still in the red after investing $20 million on Shark Tank).

• Myth 2: You must raise money before building.

  • Reality: Founders should build a minimal viable product and acquire initial users to create leverage before seeking capital.
  • Fact: Technology costs for prototyping and hosting are at historic lows, and user acquisition via platforms like Product Hunt and Hacker News is accessible.
  • Case Study: Solugen (Winter 2017) built a desk-sized reactor, then a larger version to sell hydrogen peroxide to hot tub supply stores, generating $10,000/month before raising a $4 million seed round; they have since raised $400 million.

• Myth 3: Startups must "impress" investors with flashy presentations.

  • Reality: Investors are convinced by demonstrating product utility and value creation, not by "magic words" or elaborate decks.
  • Case Study: Retool (Seed round) raised successfully because founder David Wengroff skipped the deck, instead using a crude version of the software to build an internal tool live for investors and explaining customer value.
  • Current Status: Retool is now valued at $4 billion.
  • Strategy: Investors prefer plain language explaining how a product could be 1% likely to become huge over attempts to wow an audience.

• Myth 4: Fundraising is complicated, slow, and expensive.

  • Reality: Seed rounds are often small ($500k–$2M), closed in weeks, and require minimal legal fees.
  • Mechanism: YC's SAFE (Simple Agreement for Future Equity) document, created in 2013, standardizes early fundraising.
  • SAFE Details: The document is 5 pages long, typically involves only two terms (valuation cap and discount, though discounts are rarely used), and requires no lawyers.
  • Efficiency: Platforms like Clerky allow founders to sign and send SAFEs in clicks, bypassing months of legal review.
  • Case Study: Asher Bio (Summer 2019), a capital-intensive biotech startup, raised an initial $1 million via SAFEs from angels to accelerate lab progress before securing $150 million+ from pharma investors.

• Myth 5: Raising money means losing control of the company.

  • Reality: SAFE-based seed rounds allow founders to retain total control with no board seats or information rights granted immediately.
  • Mechanism: SAFEs do not transfer shares until the next equity round; thus, no voting rights or financial reporting obligations exist for early investors.
  • Outcome: Founders sell only 10–20% of the company while keeping the ability to dictate company direction.
  • Case Study: Zapier (Summer 2012) raised over $1 million via SAFEs, chose to go fully remote 10 years before it was industry standard, and never raised additional funding, growing to $100 million in revenue.

• Myth 6: You need a fancy network or pedigree to raise money.

  • Reality: Investors prioritize revenue and product-market fit over university affiliation or Silicon Valley connections.
  • Case Study: Podium (two founders from Utah with no Silicon Valley network) entered YC while making money selling software to tire shops; they generated tens of thousands in monthly revenue and raised over $200 million.
  • Current Valuation: Podium now generates $100 million in annual revenue.
  • Recommendation: Founders should never outsource investor meetings to "networking" consultants; they must own the relationship themselves.

• Myth 7: Investor rejection implies the startup is bad.

  • Reality: Rejection is a standard part of the process, even for eventually successful companies; founders only need a few investors to believe.
  • Case Study: Envision (medical device startup) faced over 50 rejections for its first check; founder Serby Sarna offered to forgo salary for two years to secure a $25,000 bet. The company was later acquired for $275 million.
  • Case Study: Whatnot (collectibles marketplace) received significant rejection and only raised a fraction of its seed target during YC Winter 2020 despite having a beta product.
  • Current Status: Whatnot is valued at $3.7 billion two and a half years later, having raised over $400 million.

Strategic Conclusions and Forward-Looking Statements

• Bootstrapping vs. Fundraising: Forever bootstrapping extends the financial pain of fundraising across the entire company lifecycle, often forcing detours like consulting and creating constant survival anxiety; taking the pain upfront via fundraising provides stability and speed.
• Market Conditions: There has never been a better historical time to raise money due to the unprecedented volume of available investor capital.
• Core Directive: Founders should immediately focus on building products people want rather than worrying about pitch perfection, networking, or securing funding first.